Relay Therapeutics, Inc. (RLAY) Discusses Mutant Selective PI3K-alpha Inhibitor for PIK3CA-Driven Vascular Anomalies - Slideshow By Cyber Scout · April 6, 2026 · 1 min read rlaysa transcripts Source: seekingalpha.com